EHC

Business Context and Reporting Period

This Form 10-Q covers the quarterly period ended June 30, 2007, for HealthSouth Corporation (referred to as Encompass Health Corp in the request metadata, but identified as HealthSouth in the filing text). The company is the largest provider of inpatient rehabilitation services in the United States. During this period, HealthSouth executed a strategic repositioning to become a "pure-play" post-acute care provider by divesting its surgery centers, outpatient, and diagnostic divisions. These divested units are reported as discontinued operations.

Key Financial Metrics

Material Changes vs. Prior Period

• Profitability Surge: Net income swung from a loss of $42.4 million in the prior year quarter to a profit of $468.3 million. This is primarily driven by a $467.2 million gain from discontinued operations (divestitures), whereas continuing operations generated only $1.1 million in income.
• Debt Reduction: Total debt decreased from $3.4 billion as of December 31, 2006, to $2.4 billion as of June 30, 2007. Proceeds from the sale of the surgery centers ($920 million) and outpatient divisions ($245 million) were used to pay down debt.
• Operating Expenses: Total operating expenses for continuing operations decreased 7.3% year-over-year to $389.1 million, largely due to a $23.4 million benefit from government and class action settlements (reduction in liability) and lower professional fees.
• Impairment Charges: The company recorded a $14.7 million impairment charge related to its corporate campus, which was written down to fair value in anticipation of a sale (later terminated).

Guidance, Outlook, and Risks

• Strategic Focus: Management is now focused entirely on inpatient rehabilitation facilities (IRFs) and complementary post-acute services. The company plans to pursue growth through bed expansion, consolidation, and new facility development (5-8 projects in 2007).
• Regulatory Risks (75% Rule): The company faces volume volatility due to the "75% Rule" regarding patient mix. While most facilities currently meet the 60% threshold, some face higher thresholds in 2007, potentially causing volume declines in the fourth quarter.
• Liquidity and Settlements: The company remains highly leveraged. It must make final settlement payments of $43.7 million for the Medicare Program Settlement and $25.0 million for the SEC Settlement by the end of 2007. Management expects to receive income tax refunds in late 2007 or early 2008 to further deleverage.
• Internal Controls: Management concluded that disclosure controls and procedures were ineffective as of June 30, 2007, due to a material weakness in internal controls over accounting for income taxes that persisted from the prior year.

Investor Verification Checklist

• Continuing Operations Viability: Verify the sustainability of the core inpatient business, which reported a loss from continuing operations of $28.1 million for the six-month period, excluding the one-time gains from divestitures.
• Divestiture Closing Conditions: Confirm the finalization of regulatory approvals for facilities not yet transferred in the surgery centers and outpatient sales, which could impact the final purchase price and deferred gains.
• Settlement Obligations: Monitor the cash outflow required for the remaining Medicare and SEC settlement payments due in the remainder of 2007.
• Internal Control Remediation: Assess the timeline and effectiveness of plans to remediate the material weakness in income tax accounting controls.
• 75% Rule Compliance: Track patient mix compliance rates for facilities with June and May cost reporting year-ends to gauge potential revenue impacts in Q4 2007.